Catalyst Wire Dossier Catalyst Wire Dossier

Ampicillin-sulbactam

Ampicillin-sulbactam
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Ampicillin-sulbactam, covering 2010-06-07 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex [Phase 3]

See pricing